New partnership to build advanced predictive testing for blood cancer multiple myeloma

(RCSI) By combining genomic testing and next generation sequencing technology, a new partnership led by RCSI researchers aims to advance predictive tests for multiple myeloma (MM), the second most common blood cancer in Ireland.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news